Lupus Patients Continue Seeking Experimental CAR-T Therapies After Trial Deaths
Doctors say lupus patients are pursuing experimental CAR-T therapies despite recent deaths of four patients in clinical trials for various autoimmune diseases.
Related stories
DUFFY: WE NEED L3HARRIS OR WHOEVER PROVIDED ROUTER TO DO A BETTER JOB
L impact | EQUITY | Nov 14, 2026, 04:32 PM UTC
PVR INOX Pictures Acquires Rights to Three International Film Releases
PVR INOX Pictures acquired distribution rights to The Hunger Games: Sunrise on the Reaping, Godzilla Minus Zero and other titles.
M impact | EQUITY | Nov 14, 2026, 04:10 PM UTC
Nearly 3,900 Flights Canceled After FAA Groundstop, Over 2,300 Delayed
The FAA groundstop ended after four hours, but airlines continued to face disruptions on Saturday, with nearly 3,900 flights canceled and more than 2,300 delayed.
M impact | EQUITY | Nov 14, 2026, 03:52 PM UTC
Thousands of US Flights Canceled or Delayed as System Recovers
Thousands of US flights were canceled or delayed as air travel recovered from a shutdown.
M impact | EQUITY | Nov 14, 2026, 03:50 PM UTC
Mercedes-Benz Freezes New Investment in Germany, Considers Factory Closures
Mercedes-Benz has frozen new investment in Germany and put factory closures on the table, as costs deepen. The report cites a 31% Q3 2026 decline in China sales and a full-year pas
M impact | EQUITY | Nov 14, 2026, 03:01 PM UTC
MSC Nears Deal to Acquire 80% Stake in Meyer Werft, Spiegel Reports
The German government and Lower Saxony are nearing a deal giving Geneva-based shipping group MSC the right to acquire about 80% of the German shipbuilder's shares, Spiegel reported
M impact | EQUITY | Nov 14, 2026, 12:11 PM UTC